AAAAAA

   
Results: 1-12 |
Results: 12
Interferon as therapy for multiple myeloma: an individual patient data overview of 24 randomized trials and 4012 patients
Authors: Casassus, P Gibson, J Joshua, DE Matthews, J Diaz, JC Gertz, MA Kyle, R Leong, T Oken, MM Fritz, E Ludwig, H Corrado, C Lastiri, F Peest, D Grosbois, B Vela-Ojeda, J Avvisati, G Mandelli, F Petrucci, MT Capnist, G Child, JA Drayson, MT Dunn, J MacLennan, I Mellstedt, H Osterborg, A Rodjer, S Turesson, I Westin, J Bergsagel, D Browman, GP Shustik, C Zee, B Hjorth, M Holmberg, E Rodjer, S Turesson, I Westin, J Alison, R Clarke, M Elphinstone, P Evans, V Gray, R Hicks, C James, S MacKinnon, L Peto, R Richards, S Wheatley, K Blade, J Fontanillas, M San Miguel, J Aitchison, R Newland, AC Cunningham, D Malpas, J Powles, RL Montuoro, A Jacobson, J Salmon, S
Citation: P. Casassus et al., Interferon as therapy for multiple myeloma: an individual patient data overview of 24 randomized trials and 4012 patients, BR J HAEM, 113(4), 2001, pp. 1020-1034
Disease features in acute myeloid leukemia with t(8;21)(q22;g22). Influence of age, secondary karyotype abnormalities, CD19 status, and extramedullary leukemia on survival
Authors: Rege, K Swansbury, GJ Atra, AA Horton, C Min, T Dainton, MG Matutes, E Durosinmi, M Treleaven, JG Powles, RL Catovsky, D
Citation: K. Rege et al., Disease features in acute myeloid leukemia with t(8;21)(q22;g22). Influence of age, secondary karyotype abnormalities, CD19 status, and extramedullary leukemia on survival, LEUK LYMPH, 40(1-2), 2000, pp. 67-77
Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia
Authors: Davies, SM Ramsay, NKC Klein, JP Weisdorf, DJ Bolwell, B Cahn, JY Camitta, BM Gale, RP Giralt, S Heilmann, C Henslee-Downey, PJ Herzig, RH Hutchinson, R Keating, A Lazarus, HM Milone, GA Neudorf, S Perez, WS Powles, RL Prentice, HG Schiller, G Socie, G Vowels, M Wiley, J Yeager, A Horowitz, MM
Citation: Sm. Davies et al., Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia, J CL ONCOL, 18(2), 2000, pp. 340-347
Oral idarubicin as a single agent therapy in patients with relapsed or resistant multiple myeloma
Authors: Sumpter, K Powles, RL Raje, N Ramiah, V Kulkarni, S Treleaven, J Mainwaring, PN
Citation: K. Sumpter et al., Oral idarubicin as a single agent therapy in patients with relapsed or resistant multiple myeloma, LEUK LYMPH, 35(5-6), 1999, pp. 593-597
Acute erythroid leukemia (M6): Outcome of bone marrow transplantation
Authors: Killick, S Matutes, E Powles, RL Min, T Treleaven, JG Rege, KP Atra, A Catovsky, D
Citation: S. Killick et al., Acute erythroid leukemia (M6): Outcome of bone marrow transplantation, LEUK LYMPH, 35(1-2), 1999, pp. 99
Outcome of biphenotypic acute leukemia
Authors: Killick, S Matutes, E Powles, RL Hamblin, M Swansbury, J Treleaven, JG Zomas, A Atra, A Catovsky, D
Citation: S. Killick et al., Outcome of biphenotypic acute leukemia, HAEMATOLOG, 84(8), 1999, pp. 699-706
Syngeneic transplantation in multiple myeloma - a case-matched comparison with autologous and allogeneic transplantation
Authors: Gahrton, G Svensson, H Bjorkstrand, B Apperley, J Carlson, K Cavo, M Ferrant, A Fouillard, L Gratecos, N Gratwohl, A Guilhot, F Deliliers, GL Ljungman, P Masszi, T Milligan, DW Powles, RL Reiffers, J Samson, JD Stoppa, AM Vernant, JP Volin, L Wallvik, J
Citation: G. Gahrton et al., Syngeneic transplantation in multiple myeloma - a case-matched comparison with autologous and allogeneic transplantation, BONE MAR TR, 24(7), 1999, pp. 741-745
Recombinant tissue plasminogen activator (rtPA) for the treatment of hepatic veno-occlusive disease (VOD)
Authors: Kulkarni, S Rodriguez, M Lafuente, A Mateos, P Mehta, J Singhal, S Saso, R Dait, D Treleaven, JG Powles, RL
Citation: S. Kulkarni et al., Recombinant tissue plasminogen activator (rtPA) for the treatment of hepatic veno-occlusive disease (VOD), BONE MAR TR, 23(8), 1999, pp. 803-807
Impact of previous high-dose therapy on outcome after allografting for multiple myeloma
Authors: Kulkarni, S Powles, RL Treleaven, JG Singhal, S Saso, R Horton, C Killick, S Tait, D Ramiah, V Mehta, J
Citation: S. Kulkarni et al., Impact of previous high-dose therapy on outcome after allografting for multiple myeloma, BONE MAR TR, 23(7), 1999, pp. 675-680
Vaginal stenosis following allogeneic bone marrow transplantation for acute myeloid leukaemia
Authors: DeLord, C Treleaven, J Shepherd, J Saso, R Powles, RL
Citation: C. Delord et al., Vaginal stenosis following allogeneic bone marrow transplantation for acute myeloid leukaemia, BONE MAR TR, 23(5), 1999, pp. 523-525
Systemic candidiasis with candida vasculitis due to Candida kruzei in a patient with acute myeloid leukaemia
Authors: Gregory, RK Powles, RL Treleaven, JG Smith, ML Mortimer, PS Wotherspoon, A Riley, U
Citation: Rk. Gregory et al., Systemic candidiasis with candida vasculitis due to Candida kruzei in a patient with acute myeloid leukaemia, BONE MAR TR, 23(1), 1999, pp. 103-104
Remission of Crohn's disease following allogeneic bone marrow transplant for acute leukaemia
Authors: Talbot, DC Montes, A Teh, WL Nandi, A Powles, RL
Citation: Dc. Talbot et al., Remission of Crohn's disease following allogeneic bone marrow transplant for acute leukaemia, HOSP MED, 59(7), 1998, pp. 580-581
Risultati: 1-12 |